5-position modified pyrimidines and their use
US10221207B2 · kind B2 · utility
11Cited by
45References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2017 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Jul 14, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.